The quest to eradicate obesity

Armed with billions in profits and years of data, Novo Nordisk and Eli Lilly are moving to the next phase of the obesity revolution.

December 27, 2023 Check out STAT+

Sponsored By

Marian F. Moratinos for STAT STAT+ | What comes after Wegovy? The quest to eradicate obesity Armed with billions in profits and years of data, Novo Nordisk and Eli Lilly are moving to the next phase of the obesity revolution. By Elaine Chen and Andrew Joseph and Damian Garde STAT+ | Philips pays $2.4 million for allegedly giving kickbacks to sleep labs Philips Respironics paid $2.4 million to settle allegations that it gave free masks to sleep labs in an effort to boost prescriptions. By Lizzy Lawrence STAT+ | 3 FDA staffers to watch in 2024 The FDA has a lot on its plate in 2024 with the reorganizations of its food center and the office that inspects FDA-regulated facilities. By John Wilkerson Christine Kao/STAT STAT+ | 3 issues to watch in pharma in 2024 The fundamental issues and intriguing stories that characterized the year gone by will continue to loom. By Ed Silverman Opinion: Remembering Betty Rollin, who told her breast surgeon that post-operative appearance mattered to her—and other women Betty Rollin, who died recently at 87, was an activist not only for women with breast cancer but also for end-of-life issues. By Barron H. Lerner Violet CEO on measuring clinician inclusiveness: 'It's almost like a credit score' Violet trains clinicians on identity-centered health care, particularly for patients who typically face greater barriers to quality care. By Nicholas St. Fleur

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser